BRCA Testing in Serbia and Montenegro

BRCA Testing in Serbia and Montenegro

Bibliographic Details
Main Author:	Brankovic-Magic Mirjana
Format:	Article
Language:	English
Published:	BMC 2006-10-01
Series:	Hereditary Cancer in Clinical Practice
Subjects:	BRCA1 and BRCA2 testing HBOC
Online Access:	http://www.hccpjournal.com/content/4/1/12

Similar Items

Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01)

Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01)

Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples
by: Falk Zakrzewski, et al.
Published: (2019-04-01)

Age and Geographical Distribution in Families with <it>BRCA1/BRCA2 </it>Mutations in the Slovak Republic
by: Ciernikova Sona, et al.
Published: (2006-12-01)

Characteristics of BRCA1/2 pathogenic germline mutations in chinese NSCLC patients and a comparison with HBOC
by: Zheyuan Xu, et al.
Published: (2021-02-01)

Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay
by: Suzette Farber-Katz, et al.
Published: (2018-07-01)

Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes
by: Gabriella Doddato, et al.
Published: (2021-05-01)

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide
by: Yosuke Hirotsu, et al.
Published: (2020-05-01)

Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes
by: Stella Lai, et al.
Published: (2015-01-01)

Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes
by: Gabriella Doddato, et al.
Published: (2021-08-01)

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
by: Lisa Krassuski, et al.
Published: (2019-08-01)

Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme
by: Anna Doraczynska-Kowalik, et al.
Published: (2022-09-01)

The Importance of Extended Analysis Using Current Molecular Genetic Methods Based on the Example of a Cohort of 228 Patients with Hereditary Breast and Ovarian Cancer Syndrome
by: Luise D. Resch, et al.
Published: (2021-09-01)

Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in <i>BRCA2</i>
by: Irene Hidalgo Mayoral, et al.
Published: (2023-02-01)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
by: Jacopo Azzollini, et al.
Published: (2022-04-01)

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
by: Branković-Magić Mirjana, et al.
Published: (2012-01-01)

Characterization of Synonymous BRCA1:c.132C>T as a Pathogenic Variant
by: Jun Li, et al.
Published: (2022-01-01)

BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis
by: Zhewen Feng, et al.
Published: (2023-08-01)

Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing
by: Carol J. Nowlen, et al.
Published: (2024-02-01)

Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance
by: Jonas Langerud, et al.
Published: (2018-11-01)

Breast MRI texture analysis for prediction of BRCA-associated genetic risk
by: Georgia Vasileiou, et al.
Published: (2020-07-01)

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01)

BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway
by: Cecilie Heramb, et al.
Published: (2018-01-01)

A qualitative reflexive thematic analysis into the experiences of being identified with a BRCA1/2 gene alteration: “So many little, little traumas could have been avoided”
by: Nikolett Zsuzsanna Warner, et al.
Published: (2022-08-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

Turkish population-based screening for first identified changes of BRCA1 and BRCA2 genes in breast and/or ovarian cancer patients
by: Tuğba Semerci Sevimli, et al.
Published: (2024-04-01)

Age of natural menopause onset in BRCA1/2 carriers – systematic review and meta-analysis
by: Łukasz Kępczyński, et al.
Published: (2021-01-01)

A study of The Frequency and Type of Mutation in Exon 11 in BRCA1 and BRCA2 Genes In Breast Cancer Women With Positive Family History
by: Noor Jassim M, et al.
Published: (2018-06-01)

A study of The Frequency and Type of Mutation in Exon 11 in BRCA1 and BRCA2 Genes In Breast Cancer Women With Positive Family History
by: Noor Jassim M, et al.
Published: (2018-06-01)

Breast cancer susceptibility genes: Options for those carrying BRCA1 mutations
by: Branković-Magić Mirjana, et al.
Published: (2002-01-01)

Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline
by: Michelle Jacobson, et al.
Published: (2021-09-01)

The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows
by: Vera Loizzi, et al.
Published: (2023-01-01)

Predisposición genética para el cáncer de mama: genes BRCA1 y BRCA2 Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes
by: Steven A Narod, et al.
Published: (2011-10-01)

Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience
by: Joon Young Hur, et al.
Published: (2020-05-01)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
by: Yuichiro Hatano, et al.
Published: (2020-03-01)

Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high‐risk breast cancer
by: Xiaozhen Wang, et al.
Published: (2019-06-01)

Screening for BRCA1 and BRCA2 mutations in breast cancer patients from mexico: the public health perspective Tamizaje de BRCA1 y BRCA2 en pacientes con cáncerde mama en méxico: perspectiva de la salud pública
by: Steven A Narod
Published: (2009-01-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
by: Qianyan Li, et al.
Published: (2021-04-01)

BRCA1 and BRCA2 Variation in Taiwanese General Population and the Cancer Cohort
by: Jiasheng Chian, et al.
Published: (2021-06-01)